Moneycontrol PRO
LAMF
LAMF

Jitendra Sriram

Jump to
  • What makes Q1 a better earnings quarter? Hear out the experts

  • Underweight on India despite 10% correction since May: HSBC

  • Sensex yr-end target 26900; cherry-pick pvt banks too: HSBC

  • More downside if monsoon disappoints; like telecom: HSBC

  • Pick Voltas, UPL: Jitendra Sriram

  • Jitendra Sriram positive on NTPC

  • HDFC Bank, IDFC top picks: Jitendra Sriram

  • Prefer Infosys, Sun Pharmaceutical: Jitendra Sriram

  • Year-end Sensex target 30100; earnings critical: HSBC India

  • Late sell-off drags Sensex 152 pts; Bank Nifty down 386 pts

  • Fed move likely pushed to Sep; mkt pause to continue: HSBC

  • See 50 bps rate cut, good equity returns in'15: HSBC India

  • HDFC Bank, ICICI Bank top picks: Jitendra Sriram

  • Overweight on India; Sensex target of 30000 for CY15: HSBC

  • Industrial recovery still away; like construction: HSBC

  • Interact with CNBC-TV18: Prefer selective IT stocks now; like TCS: HSBC

  • Neutral on India as good news discounted; like Voltas: HSBC

  • Interact with CNBC-TV18: Would look at infra selectively says HSBC India's Sriram

  • Underweight on India, fund flow disconnect a worry: HSBC

  • See immediate resistance for Nifty at 6190: JM Financial

  • Jitendra Sriram overweight on L&T, IL&FS Engineering

  • Not bullish on mkt, yr-end Sensex target at 20250: HSBC

  • Prefer Sun Pharmaceutical, Lupin: Jitendra Sriram

    Jitendra Sriram, MD & Head of Research of HSBC India is of the view that one may prefer Sun Pharmaceutical and Lupin from the pharma space.

  • Prefer TCS in IT space: Jitendra Sriram

    According to Jitendra Sriram, MD & Head of Research of HSBC India, one may prefer Tata Consultancy Services (TCS) in the IT space.

  • Maintain year-end Sensex target of 20700: HSBC

    Within the EM space, India is still finding some favour, says Jitendra Sriram, MD & Head of Research, HSBC India.

Advisory Alert: It has come to our attention that certain individuals are representing themselves as affiliates of Moneycontrol and soliciting funds on the false promise of assured returns on their investments. We wish to reiterate that Moneycontrol does not solicit funds from investors and neither does it promise any assured returns. In case you are approached by anyone making such claims, please write to us at grievanceofficer@nw18.com or call on 02268882347